Welcome to Prism!

Upload scholarly work, create communities, get citable links and more. To get the most out of Prism, log in with your NetID and check out our guide.

Published 2002 | Version v1.0.0
Journal Article Open

Trial of Divalproex for Bipolar Disorder

Abstract

The safety and effectiveness of divalproex sodium (Depakapote) in the treatment of 40 children and adolescents, aged 7 to 19 years, with a primary diagnosis of bipolar disorder were evaluated by open-label study (2-8 weeks) at the University of Texas, Galveston; University of Pennsylvania, Philadelphia; SUNY Stonybrook, NY; Massachusetts General Hospital, Boston; and University of Texas, San Antonio.

Files

PNB-16-74-a.pdf
Files (1.4 MB)
Name Size Download all
md5:187c6ec7c395a89bac752ec960920481
1.4 MB Preview Download

Additional details

Created:
March 30, 2023
Modified:
March 30, 2023